Showing posts with label (sotagliflozin) as Potential Treatment for Type 1 Diabetes. Show all posts
Showing posts with label (sotagliflozin) as Potential Treatment for Type 1 Diabetes. Show all posts
Thursday, August 16, 2018

FDA to Review Zynquista (sotagliflozin) as Potential Treatment for Type 1 Diabetes

›
The U.S. Food and Drug Administration (FDA) has accepted Sanofi's regulatory filing for Zynquista (sotagliflozin). The investigational...